Asami Shindome

Title: Asami Shindome: Innovator in Antitussive Pharmaceutical Composition

Introduction

Asami Shindome is a notable inventor based in Kumamoto, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive agents. Her innovative work has led to the creation of a unique composition aimed at alleviating cough symptoms.

Latest Patents

Asami Shindome holds a patent for a plasma protein effective for suppressing cough. The activated Factor XI is provided as an antitussive for cough caused by stimulation at the tracheal bifurcation, such as chronic cough. The pharmaceutical composition includes a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier. This polypeptide chain consists of a full-length amino acid sequence constituting activated Factor XI, with possible modifications such as deletions, substitutions, or additions.

Career Highlights

Throughout her career, Asami has worked with esteemed organizations, including the Chemo-Sero-Therapeutic Research Institute and Ginkgo Academy Kumamoto Health Science University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Asami has collaborated with notable colleagues, including Shintaro Kamei and Takayoshi Hamamoto. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Asami Shindome's contributions to the pharmaceutical industry, particularly in developing antitussive agents, highlight her role as an influential inventor. Her work continues to impact the field positively, showcasing the importance of innovation in healthcare.